Search

Search Constraints

You searched for: Author/Creator Yaremko, Brian

Search Results

1. 157: A Phase II Trial Measuring the Integration of Stereotactic Ablative Radiotherapy (SABR) Plus Surgery in Operable Patients with Early Non-Small Cell Lung Cancer (Missile-NSCLC): Interim Safety Results. (September 2016)

2. 242: Phase I Study of Cisplatin/Docetaxel Chemotherapy with Concurrent Thoracic Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer. (September 2016)

4. 42 Circulating Tumour Cells Predict Outcome in Trimodality Management of Advanced Non-Metastatic Esophageal Cancer. (October 2019)

5. 88: The use of Respiratory Gating for Delivery of Stereotactic Ablative Radiotherapy (SABR): Is there an Impact on Oncologic Outcomes?. (September 2016)

6. 91 Quality of Life Outcomes After Stereotactic Ablative Radiotherapy (SABR) Versus Standard of Care Palliative Treatments: A Secondary Analysis of the SABR-COMET Randomized Trial. (October 2019)

7. A proposed framework for consensus-based lung tumour volume auto-segmentation in 4D computed tomography imaging. (22nd January 2015)

8. Assessment of tumour response after stereotactic ablative radiation therapy for lung cancer: A prospective quantitative hybrid 18F‐fluorodeoxyglucose‐positron emission tomography and CT perfusion study. Issue 1 (3rd October 2018)

9. DCE-MRI assessment of response to neoadjuvant SABR in early stage breast cancer: Comparisons of single versus three fraction schemes and two different imaging time delays post-SABR. (March 2020)

10. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. Issue 10215 (14th December 2019)